Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults (HT)

July 1, 2026 updated by: Jeffrey F Horowitz, University of Michigan

The overall objectives are to:

  1. Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels.
  2. Systematically compare different HIIT regimens to help identify effective "doses" of HIIT that may be optimal for improving metabolic health in obese adults.
  3. Assess the ability/willingness of obese subjects to adhere to a long-term HIIT program.

Findings from these studies will greatly expand knowledge about the effects of HIIT on metabolic health, and will provide valuable information for development of programs aimed at maximizing key metabolic benefits of exercise.

Study Overview

Detailed Description

If subjects are eligible for the study, they will be randomized into one of two different exercise training groups. Before training (and twice after 3 months of training) subjects will participate in a "clinical study" in which they will be required to stay overnight in the hospital. During the clinical study, the research team will perform a series of metabolic tests. Before and after the 3 months of training, the research team will assess subjects "free-living" 24h blood sugar control using a Continuous Glucose Monitor (CGM). The research team will measure several other relevant clinical markers (e.g., whole body and regional body fat assessments [Dual Energy X-ray Absorptiometry (DEXA) and Magnetic Resonance Imager (MRI)], hepatic lipid accumulation [MRI analysis], blood lipid profile, resting metabolic rate, glycated hemoglobin [hemoglobin A1c]). After the first 3 months of training, adherence to the subjects assigned training program will be tracked for the next 9 months (1 year of training in total). One year after initiating a training program, subjects will be asked to return to the clinic for a quick follow-up visit where the research team will complete some standard clinical assessments (e.g., body weight, body composition, blood pressure, and a blood sample).

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48178
        • Suzette Howton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 18-40
  • Body Mass Index: 30-40 kg/m2
  • Waist circumference: 88-98cm for women and 100-110cm for men
  • No regularly planned exercise/physical activity
  • Women must have regularly occurring menses and must be premenopausal

Exclusion Criteria:

  • EKG abnormalities as assessed by the cardiologist on the research team
  • Evidence/history of cardiovascular or metabolic disease
  • Medications known to affect lipid or glucose metabolism
  • Pregnant or lactating
  • Tobacco or e-cigarette use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: High Intensity Interval Training (HIIT)
Obese adults with impaired glucose tolerance will be randomized into one of two different exercise training groups for a 3 month exercise intervention.
(HIIT) 10 x 1 min. at ~90%HRmax - with low intensity warm-up, recovery, and cool down - total of 25 min/session .
Other: Moderate intensity continuous training (MICT)
Obese adults with impaired glucose tolerance will be randomized into one of two different exercise training groups for a 3 month exercise intervention.
Moderate-intensity continuous training (MICT) = steady-state exercise at 60-70%HRmax for 45min. Representing a commonly prescribed exercise program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin Sensitivity
Time Frame: Change from Baseline after 3 months of exercise training
A hyperinsulinemic-euglycemic clamp was used to assess peripheral insulin sensitivity. Briefly, a primed, continuous infusion of insulin (40 mU/m^2/min) was administered; blood glucose was assessed every 5 minutes and 20% dextrose (D20 enriched with [6-6 d2]glucose) was infused at a variable rate to accommodate changes in blood glucose in order to maintain blood glucose at the participants' overnight fasted levels. About 2 hours after beginning the insulin infusion, when blood glucose concentration stabilized without further changes in the rate of D20 infusion for ≥ ~20 minutes, arterialized blood samples were collected every 5 minutes during the final 20 minutes of the clamp for the determination of steady state tracer-labeled glucose enrichment in plasma to calculate the rate of glucose disposal.
Change from Baseline after 3 months of exercise training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VO2peak
Time Frame: Change from Baseline after 3 months of exercise training
Change in aerobic capacity between baseline and after 3 months of training
Change from Baseline after 3 months of exercise training
Resting Metabolic Rate
Time Frame: Change from Baseline after 3 months of exercise training
energy expenditure while at rest
Change from Baseline after 3 months of exercise training
Hepatic Fat %
Time Frame: Change from Baseline after 3 months of exercise training
Change in abundance of fat in the liver - reported as % area (measured by MRI)
Change from Baseline after 3 months of exercise training
Visceral Fat Area (cm^2)
Time Frame: Change from Baseline after 3 months of exercise training
Change in fat accumulation in the visceral region - measured by MRI
Change from Baseline after 3 months of exercise training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeff Horowitz, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2016

Primary Completion (Actual)

May 4, 2022

Study Completion (Actual)

May 4, 2022

Study Registration Dates

First Submitted

March 2, 2016

First Submitted That Met QC Criteria

March 7, 2016

First Posted (Estimated)

March 11, 2016

Study Record Updates

Last Update Posted (Actual)

August 24, 2026

Last Update Submitted That Met QC Criteria

July 1, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe